Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: RemI for Post-Bariatric Surgery Weight Regain [NA]

View source ↗

Summary

A clinical trial update indicates RemI is being studied for weight regain after bariatric surgery and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RemI

Snippet

Sponsor: Temple University | Conditions: Obesity, Bariatric Surgery Candidate | NA | Status: RECRUITING